# Canadian Real-World Evidence: Observational 24-Week Outcomes for Health Care Practitioner Authorized Cannabis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-real-world-effectiveness-24-week-study/ > **Published:** 2026-03-26T03:10:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:38:33-04:00 > **Clinical Summary:** Explore medical cannabis real-world effectiveness in a 24-week Canadian observational study for health care practitioner authorized use. --- CED Clinical Relevance  #92High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic PainSleepAnxietyDepressionReal-World Evidence Journal Canadian journal of pain = Revue canadienne de la douleur Study Type Observational Study Population Human participants Why This Matters This large Canadian observational study provides real-world evidence on [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) effectiveness across multiple symptom domains over 24 weeks, filling a critical gap in long-term clinical outcomes data. The study’s design mirrors actual clinical practice where patients have product choice with physician guidance, making findings more applicable to everyday care decisions. Clinical Summary This prospective multicenter observational study followed adult Canadian patients using Health Canada-verified [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) over 24 weeks, with outcomes assessed at weeks 0, 6, 12, and 24. Patients could choose from available products through a national pharmacy platform with physician guidance. The study measured pain interference (PROMIS), pain scores (NPRS), sleep duration, anxiety (GAD-7), depression (PHQ-9), and [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) (EQ-5D-3L) using validated instruments. As an observational study, it lacks the controlled conditions of randomized trials but offers valuable real-world effectiveness data across multiple symptom domains in a clinically relevant timeframe. Dr. Caplan’s Take “This study design closely mirrors how I actually practice – patients selecting from regulated products with clinical oversight rather than standardized dosing protocols. The 24-week timeframe captures the clinical reality that cannabis effects often evolve over months, not weeks.” Clinical Perspective 🧠 Clinicians should view this as complementary evidence to randomized trials, particularly valuable for understanding long-term trajectories and multi-symptom responses. Patients can be counseled that real-world outcomes data supports [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) consideration for chronic conditions, though individual responses remain highly variable and require ongoing clinical monitoring. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Canadian%20real-world%20evidence%3A%20observational%2024-week%20outcomes%20for%20health%20care%20pra...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41640820/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41640820/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Canadian%20real-world%20evidence%3A%20observational%2024-week%20outcomes%20for%20health%20care%20pra...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41640820/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41640820/](https://pubmed.ncbi.nlm.nih.gov/41640820/) Table of Contents - [FAQ](#FAQ)[What conditions showed the most improvement with medical cannabis treatment in this study?](#What_conditions_showed_the_most_improvement_with_medical_cannabis_treatment_in_this_study) - [How long does it take to see benefits from medical cannabis treatment?](#How_long_does_it_take_to_see_benefits_from_medical_cannabis_treatment) - [What makes this study different from other medical cannabis research?](#What_makes_this_study_different_from_other_medical_cannabis_research) - [How were treatment outcomes measured and validated?](#How_were_treatment_outcomes_measured_and_validated) - [Can patients choose their own medical cannabis products in this treatment model?](#Can_patients_choose_their_own_medical_cannabis_products_in_this_treatment_model) - [Related](#Related) ## FAQ #### What conditions showed the most improvement with medical cannabis treatment in this study? The study evaluated medical cannabis effectiveness for [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), sleep disorders, anxiety, and depression over 24 weeks. Based on the validated assessment tools used (PROMIS for pain interference, GAD-7 for anxiety, PHQ-9 for depression), patients showed measurable improvements across multiple domains with physician-guided treatment. #### How long does it take to see benefits from medical cannabis treatment? This study tracked outcomes at 6, 12, and 24-week intervals, providing evidence for both short-term and longer-term effects. The progressive assessment design allows clinicians to monitor treatment response and adjust therapy as needed over the 6-month treatment period. #### What makes this study different from other medical cannabis research? This was a real-world evidence study using Health Canada-verified products dispensed through a national pharmacy platform with physician guidance. Unlike controlled trials, this approach reflects actual clinical practice and provides more generalizable outcomes for diverse patient populations. #### How were treatment outcomes measured and validated? The study used clinically validated assessment tools including PROMIS for pain interference (scale 6-30), NPRS for pain scores (0-10), GAD-7 for anxiety (0-21), PHQ-9 for depression (0-27), and EQ-5D-3L for [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) (0-10). These standardized measures allow for objective comparison with other treatments and clinical benchmarks. #### Can patients choose their own medical cannabis products in this treatment model? Patients had access to Health Canada-verified [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) through a national pharmacy platform, but selection was made with physician guidance rather than independently. This supervised approach ensures appropriate product selection while allowing for individualized treatment based on patient needs and response. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41640820/”, “about”: “canadian journal pain revue canadienne de”, “isPartOf”: “Canadian journal of pain = Revue canadienne de la douleur”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.](https://cedclinic.com/medical-cannabis-real-world-effectiveness-chronic-conditions-24-week-study/) Detailed insights into a 24-week observational study on medical cannabis effectiveness in Canada. [Read More](https://cedclinic.com/medical-cannabis-real-world-effectiveness-chronic-conditions-24-week-study/) [Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) Explore findings from a large study showing pain relief benefits from medical [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). [Learn More](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) [Patients who use medical CBD are finding relief from anxiety and pain – USA Today](https://cedclinic.com/patient-reported-outcomes-medical-cbd-anxiety-pain-relief/) Discover how medical CBD is helping patients manage anxiety and pain effectively. [Discover More](https://cedclinic.com/patient-reported-outcomes-medical-cbd-anxiety-pain-relief/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).